These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21670491)

  • 1. Phosphorylation of AKT: a mutational analysis.
    Hart JR; Vogt PK
    Oncotarget; 2011 Jun; 2(6):467-76. PubMed ID: 21670491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
    Bai D; Ueno L; Vogt PK
    Int J Cancer; 2009 Dec; 125(12):2863-70. PubMed ID: 19609947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
    Boulbes D; Chen CH; Shaikenov T; Agarwal NK; Peterson TR; Addona TA; Keshishian H; Carr SA; Magnuson MA; Sabatini DM; Sarbassov dos D
    Mol Cancer Res; 2010 Jun; 8(6):896-906. PubMed ID: 20501647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic signaling of class I PI3K isoforms.
    Denley A; Kang S; Karst U; Vogt PK
    Oncogene; 2008 Apr; 27(18):2561-74. PubMed ID: 17998941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways leading to oxidative stress-induced phosphorylation of Akt.
    Lahair MM; Howe CJ; Rodriguez-Mora O; McCubrey JA; Franklin RA
    Antioxid Redox Signal; 2006; 8(9-10):1749-56. PubMed ID: 16987028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks.
    Fraser M; Harding SM; Zhao H; Coackley C; Durocher D; Bristow RG
    Cell Cycle; 2011 Jul; 10(13):2218-32. PubMed ID: 21623170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
    Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
    Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.
    Denley A; Gymnopoulos M; Kang S; Mitchell C; Vogt PK
    Mol Cancer Res; 2009 Jul; 7(7):1132-8. PubMed ID: 19584261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
    Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
    Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
    Akagi T; Murata K; Shishido T; Hanafusa H
    Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling.
    Edouard T; Combier JP; Nédélec A; Bel-Vialar S; Métrich M; Conte-Auriol F; Lyonnet S; Parfait B; Tauber M; Salles JP; Lezoualc'h F; Yart A; Raynal P
    Mol Cell Biol; 2010 May; 30(10):2498-507. PubMed ID: 20308328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling.
    Rodrik-Outmezguine VS; Chandarlapaty S; Pagano NC; Poulikakos PI; Scaltriti M; Moskatel E; Baselga J; Guichard S; Rosen N
    Cancer Discov; 2011 Aug; 1(3):248-59. PubMed ID: 22140653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation.
    Guo JP; Coppola D; Cheng JQ
    J Biol Chem; 2011 Oct; 286(43):37389-98. PubMed ID: 21908616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
    Zhao L; Li R; Gan YH
    Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells.
    Hunzicker-Dunn ME; Lopez-Biladeau B; Law NC; Fiedler SE; Carr DW; Maizels ET
    Proc Natl Acad Sci U S A; 2012 Oct; 109(44):E2979-88. PubMed ID: 23045700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication.
    Soares JA; Leite FG; Andrade LG; Torres AA; De Sousa LP; Barcelos LS; Teixeira MM; Ferreira PC; Kroon EG; Souto-Padrón T; Bonjardim CA
    J Virol; 2009 Jul; 83(13):6883-99. PubMed ID: 19386722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis.
    Zuo B; Li M; Liu Y; Li K; Ma S; Cui M; Qin Y; Zhu H; Pan X; Guo J; Dai Z; Yu W
    Leuk Lymphoma; 2015 Jul; 56(7):2170-81. PubMed ID: 25363403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt.
    Wick MJ; Dong LQ; Hu D; Langlais P; Liu F
    J Biol Chem; 2001 Nov; 276(46):42843-50. PubMed ID: 11551902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yak OXGR1 promotes fibroblast proliferation via the PI3K/AKT pathways.
    Wang Q; Zhang Q; Zhang Y; Zhao X
    J Cell Biochem; 2019 Apr; 120(4):6729-6740. PubMed ID: 30520130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic.
    Dannemann N; Hart JR; Ueno L; Vogt PK
    Int J Cancer; 2010 Jul; 127(1):239-44. PubMed ID: 19876913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.